Media Advisory: Stem Cell Board To Consider Review Additional Research Grant Initiatives; Special Presentation on Stem Cell Research and Heart Disease

The Independent Citizens Oversight Committee (ICOC), governing board for the state agency charged with managing the $3 billion California stem cell research program, will meet Wednesday, October 3, 2007.

 WHO:  The 29-member Independent Citizens Oversight Committee (ICOC) is the governing board for the California Institute for Regenerative Medicine (CIRM). The list of board members is available at

 WHAT: The ICOC will review and consider concept releases for two new grant initiatives: Disease Team Planning Awards and New Cell Lines Awards. With the ultimate goal of funding disease teams to produce a therapy or diagnostic for a particular disease or serious injury, the CIRM staff is now proposing to offer planning grants of up to $50,000 to as many as 20 teams, to explore a new method of integrating and organizing the highest quality basic, translational, and clinical research in a team setting. The second proposal would provide up to $25 million for 16 grants aimed at deriving pluripotent stem cells from new sources. The ICOC will also consider a proposed contract for an electronic grants management system as well as a set of amendments to the CIRM Facilities Grants Administration Policy. The agenda for the meeting is available at

  The ICOC will hear a special presentation on the applicability of stem cell research to heart disease, jointly sponsored by CIRM, the University of California, San Diego, and the Burnham Institute for Medical Research. Speakers at the presentation include Janet Wright, M.D., F.A.C.C., a patient advocate member of the ICOC; Anthony DeMaria, M.D., M.A.C.C., Professor of Medicine and Director of the Sulpizio Family Cardiovascular Center at UCSD; and Mark Mercola, Ph.D., Professor and Director, Del E. Webb Neuroscience, Aging, and Stem Cell Research Center, Burnham Institute.

 WHEN:    Wednesday, October 3, 2007
                  8:30 to 9:15 a.m. Spotlight on Heart Disease
                  9:30 a.m. to 5:00 p.m. (estimated) ICOC Meeting

 WHERE:  Hilton San Diego Airport/Harbor Island
                   1960 Harbor Island Drive
                  San Diego, CA 92101

WHY:  To date, the ICOC has approved stem cell research grants totaling more than $208 million to 23 academic and non-profit research institutions in California. Another $300 million in grants are scheduled to be approved  for the development of new faculty and major research facilities  by April 2008. On Thursday, October 4th, the first $250 million of stem cell research bonds authorized by Proposition 71 will be sold to investors.


Contacts:         Dale A. Carlson        


© 2013 California Institute for Regenerative Medicine